Temporal Relationship Between Endothelin-1 Concentrations and Cerebral Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage
- 1 May 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (5) , 1185-1190
- https://doi.org/10.1161/01.str.32.5.1185
Abstract
Background and Purpose —Endothelin 1 (ET-1) is a potent vasoconstrictor that may play a role in cerebral vasospasm following subarachnoid hemorrhage (SAH). However, data regarding its pathogenic role in the development of vasospasm are controversial. We planned a prospective, observational clinical study to investigate the temporal relationship between increased ET-1 production and cerebral vasospasm or other neurological sequelae after SAH. Methods —ET-1 levels in cerebrospinal fluid (CSF) were measured in 20 SAH patients from admission (within 24 hours from the bleeding) until day 7. Patients received a daily transcranial Doppler study and a neurological evaluation. On day 7, angiography was performed to verify the degree and extent of vasospasm. Patients were then classified as having (1) clinical vasospasm, (2) angiographic vasospasm, (3) no vasospasm, or (4) poor neurological condition without significant vasospasm (low Glasgow Coma Scale score [GCS]). Results —On admission, ET-1 levels were increased in the low-GCS group compared with the other groups ( P =0.04). On day 4 ET-1 levels were not significantly different among groups, whereas on day 7 ET-1 levels were significantly increased in both the clinical vasospasm and low-GCS groups compared with the angiographic vasospasm and no vasospasm groups ( P R 2 =0.73). Conclusions —CSF ET-1 levels were markedly elevated in patients with clinical manifestations of vasospasm (day 7) and with a poor neurological condition not related to vasospasm. However, ET-1 levels were low in clinical vasospasm patients before clinical symptoms were evident (day 4) and remained low in angiographic vasospasm patients throughout the study period. Thus, our data suggest that CSF ET-1 levels are increased in conditions of severe neuronal damage regardless whether this was due to vasospasm or to the primary hemorrhagic event. In addition, CSF ET-1 levels paralleled the neurological deterioration but were not predictive of vasospasm.Keywords
This publication has 33 references indexed in Scilit:
- Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1995
- Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage modelJournal of Neurosurgery, 1994
- An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogsLife Sciences, 1993
- Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: The relationship to endothelin-1 levels in the cerebrospinal fluidLife Sciences, 1991
- Presence of non‐selective type of endothelin receptor on vascular endothelium and its linkage to vasodilationFEBS Letters, 1991
- Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: A clinical study and literature reviewSurgical Neurology, 1991
- Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhageThe Lancet, 1990
- Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shockBiochemical and Biophysical Research Communications, 1989
- Results and complications of surgical management of 809 intracranial aneurysms in 722 casesJournal of Neurosurgery, 1982
- Relation of Cerebral Vasospasm to Subarachnoid Hemorrhage Visualized by Computerized Tomographic ScanningNeurosurgery, 1980